WAVE Life Sciences (WVE) Tops Q1 EPS by 19c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $38.25 million versus the consensus estimate of $8.34 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
• Invitation Homes prices $500 million senior notes offering at 4.950%
• Largo wins $125M U.S. defense contract for vanadium pentoxide supply